Clinical Trials Browser

Phase 1/2 × Brain Neoplasms × atezolizumab × Clear all

NCT03973879 2020-02-11

Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma

Phase 1/2 Withdrawn

Brain Neoplasms, Glioblastoma, Glioma